ADRB2 and pulmonary arterial hypertension: Although the reduction in β2AR gene expression that was present following prenatal PAH exposure, particularly in the absence of OVA sensitization, was not associated with altered AHR or loss of reversibility after administration of a β2 agonist, hence, its clinical significance is unclear.